Loading...
XSTO
DOXA
Market cap61mUSD
Jul 25, Last price  
0.46SEK
1D
-0.43%
1Q
38.79%
Jan 2017
-82.39%
IPO
-86.87%
Name

Doxa AB

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
37.99
EPS
—
Div Yield, %
—
Shrs. gr., 5y
61.08%
Rev. gr., 5y
-4.26%
Revenues
16m
+56.57%
1,823,0005,00049,000863,0001,005,0002,193,0006,159,0008,998,00015,013,00017,544,00016,330,00033,758,00019,274,0008,541,00010,900,0005,200,0009,900,00015,500,000
Net income
-1.58b
L
-38,943,000-50,288,000-33,597,000-16,455,000-62,886,000-37,379,000-19,490,000-18,488,000-15,932,000-10,743,000-10,560,0008,018,000-11,273,000-13,692,00076,200,000-33,000,000291,900,000-1,575,200,000
CFO
-63m
L+66.93%
-37,140,000-22,875,000-6,453,000-30,247,000-50,419,000-29,896,000-20,248,000-18,201,000-17,344,000-9,705,000-8,212,00010,742,000-9,174,000-14,282,000-18,600,000-38,500,000-37,800,000-63,100,000

Profile

Doxa AB (publ), a dental company, develops, manufactures, and commercializes bioceramic dental products under the Ceramir brand worldwide. It offers Crown & Bridge, a dental cement that is used for permanent cementing of crowns and bridges. The company was founded in 1987 and is based in Uppsala, Sweden.
URL
https://www.doxa.se/
IPO date
Apr 07, 2014
Employees
7
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
15,500
56.57%
9,900
90.38%
5,200
-52.29%
Cost of revenue
40,800
Unusual Expense (Income)
NOPBT
15,500
9,900
(35,600)
NOPBT Margin
100.00%
100.00%
Operating Taxes
(6,900)
Tax Rate
NOPAT
15,500
9,900
(28,700)
Net income
(1,575,200)
-639.64%
291,900
-984.55%
(33,000)
-143.31%
Dividends
Dividend yield
Proceeds from repurchase of equity
244,700
350,500
BB yield
-18.52%
-25.66%
Debt
Debt current
2,770,300
6,100
1,400
Long-term debt
869,500
14,200
10,200
Deferred revenue
Other long-term liabilities
270,200
200,200
6,700
Net debt
3,569,200
(2,614,900)
(1,756,400)
Cash flow
Cash from operating activities
(63,100)
(37,800)
(38,500)
CAPEX
(900)
Cash from investing activities
(834,900)
(205,100)
(267,300)
Cash from financing activities
807,700
294,700
350,700
FCF
(5,611,000)
(29,900)
(41,600)
Balance
Cash
70,600
111,900
60,000
Long term investments
2,523,300
1,708,000
Excess cash
69,825
2,634,705
1,767,740
Stockholders' equity
642,800
364,600
(42,600)
Invested Capital
6,102,375
3,073,600
1,823,500
ROIC
0.34%
0.40%
ROCE
0.25%
0.29%
EV
Common stock shares outstanding
944,331
387,531
281,048
Price
0.72
-78.89%
3.41
-29.84%
4.86
-62.90%
Market cap
679,918
-48.55%
1,321,482
-3.25%
1,365,894
-8.35%
EV
4,249,118
(1,293,418)
(200,406)
EBITDA
15,500
11,900
(35,500)
EV/EBITDA
274.14
5.65
Interest
22,500
2,100
1,000
Interest/NOPBT
145.16%
21.21%